CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
and pharmacodynamic effects of ACI-24.060 in subjects with prodromal Alzheimer's disease and in non-demented adults with Down syndr...
Phase 1, Phase 2
Nashville, Tennessee, United States and 18 other locations
is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Tri...
Phase 3
Nashville, Tennessee, United States and 116 other locations
Alzheimer's disease (AD) is a progressive, irreversible neurological disorder and is the most common cause of dementia in the elder...
Phase 2
Nashville, Tennessee, United States and 63 other locations
study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants with Early Alzheimer's...
Phase 2
Nashville, Tennessee, United States and 206 other locations
outpatient study in subjects with psychosis associated with Alzheimer's Disease.The primary objective of the study is to evaluate r ...
Phase 3
Franklin, Tennessee, United States of America and 105 other locations
A 76-week safety and efficacy study of simufilam (PTI-125) given twice daily to participants with mild-to-moderate Alzheimer's disease...
Phase 3
Franklin, Tennessee, United States of America and 89 other locations
This project will investigate the potential of Deep Brain Stimulation to improve cognitive abilities and counteract the effects of Alzheimer's...
Nashville, Tennessee, United States
This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...
Phase 3
Nashville, Tennessee, United States and 344 other locations
This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...
Phase 3
Nashville, Tennessee, United States and 384 other locations
This study is being conducted to evaluate the safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the AP...
Phase 3
Nashville, Tennessee, United States and 94 other locations
Clinical trials
Research sites
Resources
Legal